{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:00:05Z","timestamp":1794564005315,"version":"4.9.1"},"reference-count":33,"publisher":"BMJ","funder":[{"name":"AstraZeneca Taiwan and","award":["ESR-18-13978"],"award-info":[{"award-number":["ESR-18-13978"]}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["112A-2201"],"award-info":[{"award-number":["112A-2201"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["112A-2204"],"award-info":[{"award-number":["112A-2204"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["112A-NDMC-2222"],"award-info":[{"award-number":["112A-NDMC-2222"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["113A-2214"],"award-info":[{"award-number":["113A-2214"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009974","name":"Cardinal Tien Hospital","doi-asserted-by":"publisher","award":["113A-NDMC-2222"],"award-info":[{"award-number":["113A-NDMC-2222"]}],"id":[{"id":"10.13039\/501100009974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,3,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Short-acting \u03b22-agonist (SABA) overuse is associated with increased asthma exacerbations and mortality, yet its impact on cardiovascular disease remains unclear. We investigate the association between SABA overuse and the risk of major adverse cardiovascular events (MACE) in patients with asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 2011 and 2019, patients with asthma were identified from the Taiwan asthma pay-for-performance database. SABA overuse was defined as using \u22653 canisters annually, compared with acceptable use (0\u20132\u2009canisters\/year). Inverse probability of treatment weighting (IPTW) was applied to balance baseline covariates. The primary outcome was 1-year MACE. Secondary outcomes included MACE component (non-fatal myocardial infarction, haemorrhagic stroke, ischaemic stroke) and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 231\u2009970 patients, 28\u2009500 had SABA overuse and 203\u2009470 had acceptable use. In the IPTW-weighted cohort, 1-year MACE incidence was higher in the overuse group (2.82 vs 0.99 per 100 person-years; adjusted HR (aHR) 1.25, 95%\u2009CI 1.12 to 1.39). SABA overuse significantly increased the risk of non-fatal MI (aHR: 1.28, 95%\u2009CI 1.09 to 1.50), ischaemic stroke (aHR: 1.26, 95%\u2009CI 1.08 to 1.46) and mortality (aHR: 1.40, 95%\u2009CI 1.24 to 1.58). Haemorrhagic stroke risk was not significantly increased. A non-linear dose-response was observed, with MACE risk peaking at 6\u20138 canisters annually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SABA overuse (\u22653 canisters\/year) is associated with increased risks of MACE and mortality in patients with asthma. These findings emphasise the importance of monitoring SABA use and assessing cardiovascular risk in asthma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2024-222204","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:20:43Z","timestamp":1776273643000},"page":"thorax-2024-222204","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Association between overuse of short-acting \u03b22-agonists and the risk of major adverse cardiovascular events among patients with asthma"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-3504","authenticated-orcid":false,"given":"Chao-Hsien","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Taitung MacKay Memorial Hospital, Taitung, Taiwan"},{"name":"Department of Medicine, MacKey Medical University, New Taipei City, Taiwan"},{"name":"Master of Science in Decision Analysis, Minerva University, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-0743","authenticated-orcid":false,"given":"Cheng-Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Internal Medicine, Cardinal Tien Hospitcal and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Chien","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Division of Pulmonary Medicine, Department of Internal Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026060810201311000_thorax-2024-222204v2.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202109-2205PP"},{"key":"2026060810201311000_thorax-2024-222204v2.2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01858-2019","article-title":"SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting \u03b22-agonist use in asthma","volume":"55","author":"Cabrera","year":"2020","journal-title":"Eur Respir J"},{"key":"2026060810201311000_thorax-2024-222204v2.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01402-2021","article-title":"Short-acting \u03b22-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study","volume":"59","author":"Bateman","year":"2022","journal-title":"Eur Respir J"},{"key":"2026060810201311000_thorax-2024-222204v2.4","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01233-0"},{"key":"2026060810201311000_thorax-2024-222204v2.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01701-3","article-title":"Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany","volume":"22","author":"Worth","year":"2021","journal-title":"Respir Res"},{"key":"2026060810201311000_thorax-2024-222204v2.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"key":"2026060810201311000_thorax-2024-222204v2.7","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01444-5"},{"key":"2026060810201311000_thorax-2024-222204v2.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-02008-9","article-title":"Short-acting \u03b22-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III","volume":"22","author":"Yorganc\u0131o\u011flu","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026060810201311000_thorax-2024-222204v2.9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/02770903.2022.2082305","article-title":"Over-prescription of short-acting \u03b22-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study","volume":"60","author":"Montero-Arias","year":"2023","journal-title":"J Asthma"},{"key":"2026060810201311000_thorax-2024-222204v2.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-021-00231-1","article-title":"The prevalence and outcome of short-acting \u03b22-agonists overuse in asthma patients in Taiwan","volume":"31","author":"Wang","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026060810201311000_thorax-2024-222204v2.11","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jaip.2022.02.047","article-title":"Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America","volume":"10","author":"Quint","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026060810201311000_thorax-2024-222204v2.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.11.029"},{"key":"2026060810201311000_thorax-2024-222204v2.13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamainternmed.2017.7720","article-title":"Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study","volume":"178","author":"Wang","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2026060810201311000_thorax-2024-222204v2.14","doi-asserted-by":"crossref","unstructured":"Bloom CI , Sundaram V , Hubbard RB , et al . Association of cardiovascular disease, pulmonary embolism, and pneumonia with inhaled corticosteroid use in asthma: a uk cohort study. American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA; 2024 Available: https:\/\/www.atsjournals.org\/doi\/book\/10.1164\/ajrccm-conference.2024.D22","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A7005"},{"key":"2026060810201311000_thorax-2024-222204v2.15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/COPD.S358927","article-title":"Association between Inhaled \u03b22-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study","volume":"17","author":"Amegadzie","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060810201311000_thorax-2024-222204v2.16","doi-asserted-by":"crossref","first-page":"17915","DOI":"10.1038\/s41598-017-17890-1","article-title":"Inhaled bronchodilators and acute myocardial infarction: a nested case-control study","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"2026060810201311000_thorax-2024-222204v2.17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.rmed.2014.05.014","article-title":"Inhaled beta-2-agonists\/muscarinic antagonists and acute myocardial infarction in COPD patients","volume":"108","author":"Rottenkolber","year":"2014","journal-title":"Respir Med"},{"key":"2026060810201311000_thorax-2024-222204v2.18","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jaip.2022.03.024","article-title":"Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed","volume":"10","author":"van der Meer","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026060810201311000_thorax-2024-222204v2.19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2147\/JAA.S377896","article-title":"Characteristics of Oral Corticosteroid Users Among Persons with Asthma on GINA Step 3 Therapy and Above: A Cross-Sectional Study in Portuguese Community Pharmacies","volume":"15","author":"Rom\u00e3o","year":"2022","journal-title":"J Asthma Allergy"},{"key":"2026060810201311000_thorax-2024-222204v2.20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/02770903.2025.2450640","article-title":"Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysis","volume":"62","author":"Moore","year":"2025","journal-title":"J Asthma"},{"key":"2026060810201311000_thorax-2024-222204v2.21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jval.2020.01.024","article-title":"Nephrologist Follow-Up Care of Patients With Acute Kidney Disease Improves Outcomes: Taiwan Experience","volume":"23","author":"Wu","year":"2020","journal-title":"Value Health"},{"key":"2026060810201311000_thorax-2024-222204v2.22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2026060810201311000_thorax-2024-222204v2.23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/insr.12214","article-title":"A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications","volume":"85","author":"Austin","year":"2017","journal-title":"Int Stat Rev"},{"key":"2026060810201311000_thorax-2024-222204v2.24","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention. 2023. Available: https:\/\/ginasthma.org\/wp-content\/uploads\/2024\/05\/GINA-2023-Report-WMSA.pdf [Accessed 01 Mar 2026]."},{"key":"2026060810201311000_thorax-2024-222204v2.25","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2147\/COPD.S145913","article-title":"Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD","volume":"12","author":"Huang","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060810201311000_thorax-2024-222204v2.26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4168\/aair.2022.14.3.314","article-title":"Cardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study)","volume":"14","author":"Su","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"2026060810201311000_thorax-2024-222204v2.27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.mayocp.2021.07.020","article-title":"Cardioselective Versus Nonselective \u03b2-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease","volume":"97","author":"Chung","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"2026060810201311000_thorax-2024-222204v2.28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ejhf.647","article-title":"Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative","volume":"19","author":"Coiro","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026060810201311000_thorax-2024-222204v2.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.3.846"},{"key":"2026060810201311000_thorax-2024-222204v2.30","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.3.9904006"},{"key":"2026060810201311000_thorax-2024-222204v2.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.6.1964"},{"key":"2026060810201311000_thorax-2024-222204v2.32","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.129966"},{"key":"2026060810201311000_thorax-2024-222204v2.33","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.59.3.297"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:20:28Z","timestamp":1780939228000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":33,"alternative-id":["10.1136\/thorax-2024-222204"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222204","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}